ArticleOncogenesis2016

ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.

A Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.